Related Experiment Video
Updated: Jul 6, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus
Kazuhisa Ouhara1, Hitoshi Komatsuzawa, Toshihisa Kawai
1Department of Bacteriology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Objectives:
The susceptibility of clinical isolates of Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), to host-derived cationic antimicrobial peptides was investigated.
Methods:
We examined the susceptibility of 190 clinical strains of methicillin-susceptible S. aureus (MSSA) and 304 strains of MRSA to two different classes of cationic antimicrobial peptides: LL-37 and human beta-defensin-3 (hBD3). Out of the total 494 clinical strains, a random selection of 54 S. aureus strains was examined to establish the relationship between the net charge, or zeta potential, of each strain and its susceptibility to hBD3 or LL-37. To further confirm bacterial susceptibility to either hBD3 or LL-37, we concurrently measured: (i) percentage survival after in vitro bacterial exposure and (ii) MBCs for both MRSA and MSSA strains.
Results:
Of the 54 randomly selected S. aureus strains, those MRSA strains resistant to LL-37 showed significantly higher zeta potentials than those susceptible to LL-37 (P < 0.05). In contrast, there was no difference in bacterial zeta potentials for MRSA strains that showed either resistance or susceptibility to hBD3. In addition, resistance to LL-37, but not to hBD3, as determined by either percentage survival or MBC, was significantly elevated in highly methicillin-resistant strains of S. aureus when compared with MSSA strains (P < 0.01).
Conclusions:
Clinical strains of MRSA, but not MSSA, that demonstrated an increased net charge also showed elevated resistance to LL-37, but not to hBD3.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) with higher net charge shows increased resistance to the antimicrobial peptide LL-37, but not human beta-defensin-3 (hBD3). This finding is crucial for understanding MRSA infections and developing new treatments.
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- Staphylococcus aureus, including methicillin-resistant strains (MRSA), poses a significant threat due to antimicrobial resistance.
- Host-derived cationic antimicrobial peptides (CAPs) are crucial components of the innate immune system against bacterial pathogens.
Purpose of the Study:
- To investigate the susceptibility of clinical Staphylococcus aureus isolates, including MRSA, to host-derived CAPs LL-37 and human beta-defensin-3 (hBD3).
- To determine the relationship between bacterial net charge (zeta potential) and resistance to LL-37 and hBD3 in MRSA and methicillin-susceptible S. aureus (MSSA).
Main Methods:
- Examined susceptibility of 190 MSSA and 304 MRSA clinical strains to LL-37 and hBD3.
- Assessed zeta potential in 54 S. aureus strains to correlate with CAP susceptibility.
- Measured percentage survival and Minimum Bactericidal Concentrations (MBCs) to confirm resistance.
Main Results:
- MRSA strains resistant to LL-37 exhibited significantly higher zeta potentials compared to susceptible strains.
- No significant difference in zeta potential was observed for MRSA strains resistant or susceptible to hBD3.
- Resistance to LL-37, but not hBD3, was significantly elevated in highly methicillin-resistant S. aureus compared to MSSA.
Conclusions:
- Increased net charge in clinical MRSA strains correlates with elevated resistance to LL-37, but not hBD3.
- These findings highlight a potential mechanism of resistance to specific CAPs in MRSA.
- Understanding these interactions may inform the development of novel therapeutic strategies against MRSA infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Staphylococcal Skin Infections
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
